INIS
antioxidants
27%
applications
25%
bonding
11%
bones
11%
cancer
43%
carcinomas
11%
children
100%
comparative evaluations
34%
concentration
37%
control
11%
data
17%
dentistry
12%
diseases
14%
disturbances
11%
drugs
34%
evaluation
22%
glass
11%
hela cells
12%
humans
19%
hydrogen
12%
hydrogen 1
18%
in vitro
43%
inhibition
17%
interactions
11%
interventions
12%
investigations
16%
levels
20%
lungs
32%
males
17%
management
36%
mouth
16%
nanoparticles
27%
nmr
15%
palladium
18%
patients
25%
performance
15%
pregnenolone
18%
reliability
27%
reviews
14%
risks
15%
screening
11%
silver
18%
spectra
16%
surfaces
16%
synthesis
32%
teeth
28%
tools
13%
toxicity
11%
transmission electron microscopy
11%
values
31%
Medicine and Dentistry
Air-Abrasion
9%
Anchorage
9%
Aneurysmal Bone Cyst
9%
Anterior Teeth
9%
Antioxidant
9%
Automutilation
9%
Carcinogen
9%
Case Management
6%
Checklist
5%
Conservative Treatment
9%
Dental Caries
9%
Dental Prosthesis
9%
Dentifrice
9%
Dentistry
11%
Developmental Delay
9%
Emotional Disorder
9%
Geriatrics
9%
Giant Cell Granuloma
9%
Gingiva Fibromatosis
9%
Gingivectomy
9%
Gingivitis
9%
Halitosis
9%
Health Outcomes
9%
Implant
6%
In Silico
9%
In Vitro
9%
Jaw
7%
Joint Dislocation
9%
Klippel Feil Syndrome
9%
Lower Jaw
7%
Lung Cancer
9%
Meta-Analysis
18%
Meta-Regression
5%
Mouth
9%
Oral Submucous Fibrosis
5%
Poly(methyl Methacrylate)
9%
Pregnenolone Derivative
9%
Prevalence
9%
Random Effects Model
5%
Randomized Controlled Trial
9%
Speech Production
6%
Sucking
6%
Temporomandibular Ankylosis
9%
Temporomandibular Joint
9%
Toddlers
18%
Toe
9%
Tooth Plaque
9%
Typical Antipsychotic
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Agent
9%
Antioxidant
18%
Blumea lacera
9%
Carbon 13
14%
Carcinogen
9%
Dental Caries
10%
Dog Bite
9%
Fever
9%
Gabapentin
9%
Gingivitis
9%
Halitosis
9%
IC50
11%
Injury
6%
Ionic Liquid
9%
Klippel Feil Syndrome
9%
Lung Cancer
13%
Malignant Neoplasm
8%
Maxillofacial Injury
9%
Medicinal Plant
9%
Non-Covalent Interactions
6%
Palladium Nanoparticle
9%
Pregnenolone Derivative
9%
Prevalence
18%
Randomized Controlled Trial
9%
Silver Nanoparticle
18%
Silver Nanoparticle
18%
Tablet
9%
Temporomandibular Ankylosis
9%
Thiosemicarbazone Derivative
9%
Tooth Plaque
9%
Toothpaste
9%
Uterine Cervix Cancer
9%
Xanthene
9%